HOMA-IR: difference between revisions
Diff·revision 1 → 2·07:49, 5 Oct 2024
Difference between revision 1 and revision 2 of HOMA-IR. 5 lines changed; the page grew by 177 bytes.
| Revision 1 — 00:49, 1 Oct 2024 ApoB_Aurelio (talk) new article: laboratory medicine, expansion welcome 1,413 bytes +1,413 | Revision 2 — 07:49, 5 Oct 2024 LabRangeLindy (talk) add the body-composition measurement method to the comparison 1,590 bytes +177 | ||
|---|---|---|---|
| 10 | Its appeal is that it requires one blood draw rather than a several-hour clamp. Its weakness is that it is a model-derived approximation from two values, inherits the poor standardisation of insulin assays, and describes hepatic rather than peripheral insulin resistance most directly.{{r|wallace2004}} | 10 | Its appeal is that it requires one blood draw rather than a several-hour clamp. Its weakness is that it is a model-derived approximation from two values, inherits the poor standardisation of insulin assays, and describes hepatic rather than peripheral insulin resistance most directly.{{r|wallace2004}} |
| 11 | 11 | ||
| + | 12 | == Calculation and the two forms == | |
| + | 13 | The original linear approximation is | |
| + | 14 | ||
| + | 15 | {{math|\text{HOMA-IR} = (\text{glucose}_{\text{mmol/L}} \times \text{insulin}_{\text{mU/L}}) / 22.5}} | |
| + | 16 | ||
| 12 | == References == | 17 | == References == |
| 13 | {{reflist}} | 18 | {{reflist}} |